Amrinone vs dobutamine in elderly patients with decompensated congestive heart failure
Rich, M.W.; Woods, W.; Davila Roman, V.G.; Kurz, H.; Morello, P.J.
Journal of the American Geriatrics Society 40(10 Suppl): SA40
1992
ISSN/ISBN: 0002-8614
Accession: 029997383
PDF emailed within 1 workday: $29.90
Related References
Rich, M.W.; Woods, W.L.; Davila-Roman, V.G.; Morello, P.J.; Kurz, H.; Barbarash, R.; Spinner, L.; Sperry, J.; Beckham, V.; Coulter, L. 1995: A randomized comparison of intravenous amrinone versus dobutamine in older patients with decompensated congestive heart failure Journal of the American Geriatrics Society 43(3): 271-274Rich, M.W.; Imburgia, M. 1990: Inotropic response to dobutamine in elderly patients with decompensated congestive heart failure American Journal of Cardiology 65(7): 519-521
Klein, N.A.; Siskind, S.J.; Frishman, W.H.; Sonnenblick, E.H.; LeJemtel, T.H. 1981: Hemodynamic comparison of intravenous amrinone and dobutamine in patients with chronic congestive heart failure American Journal of Cardiology 48(1): 170-175
Aronson, D.; Burger, A.J. 2001: The effect of dobutamine on neurohormonal and cytokine profiles in patients with decompensated congestive heart failure European Heart Journal 22(Abstract Suppl): 397
Komamura, K.; Matsuo, H.; Sasaki, T. 2008: Comparison of the initial hospitalization costs between the patients treated with dobutamine and the patients treated with amrinone for acute decompensated heart failure in a Japanese institute Value in Health: the Journal of the International Society for Pharmacoeconomics and Outcomes Research 11 Suppl. 1: S39-S42
De Lissovoy, G.; Stier, D.M.; Ciesla, G.; Munger, M.; Burger, A.J. 2003: Economic implications of nesiritide versus dobutamine in the treatment of patients with acutely decompensated congestive heart failure American Journal of Cardiology 92(5): 631-633
Marcus, R.H.; Raw, K.; Patel, J.; Mitha, A.; Sareli, P. 1990: Comparison of intravenous amrinone and dobutamine in congestive heart failure due to idiopathic dilated cardiomyopathy American Journal of Cardiology 66(15): 1107-1112
Burger, A.J.; Elkayam, U.; Neibaur, M.T.; Haught, H.; Ghali, J.; Horton, D.P.; Aronson, D. 2001: Comparison of the occurrence of ventricular arrhythmias in patients with acutely decompensated congestive heart failure receiving Dobutamine versus Nesiritide therapy American Journal of Cardiology 88(1): 35-39
Marcus, R.; Sareli, P.; Raw, K.; Patel, J.; Mitha, A.; Chun, R.; Davis, J. 1989: Amrinone vs dobutamine in congestive heart failure due to dilated cardiomyopathy differences in hemodynamic effects and therapeutic implications European Heart Journal 10(ABSTR Suppl): 386
Burger, A.J.; Horton, D.P.; LeJemtel, T.; Ghali, J.K.; Torre, G.; Dennish, G.; Koren, M.; Dinerman, J.; Silver, M.; Cheng, M.L.; Elkayam, U. 2002: Effect of nesiritide (B-type natriuretic peptide) and dobutamine on ventricular arrhythmias in the treatment of patients with acutely decompensated congestive heart failure: the PRECEDENT study American Heart Journal 144(6): 1102-1108
De Vecchis, R.; Pucciarelli, G.; Nocerino, L.; Cocozza, M.; Setaro, A.; Torre, G.; Imperatore, F. 1998: The dobutamine-dopamine combination versus amrinone in congestive heart failure with a marked edematogenic sign complicated by functional kidney failure. a comparison between 2 different models of inotropic stimulation and diuresis potentiation Minerva Cardioangiologica 46(5): 163-174
Brunner-La Rocca, H.P.; Buser, P.T.; Schindler, R.; Bernheim, A.; Rickenbacher, P.; Pfisterer, M. 2006: Management of elderly patients with congestive heart failure--design of the Trial of Intensified versus standard Medical therapy in Elderly patients with Congestive Heart Failure (TIME-CHF) American Heart Journal 151(5): 949-955
Nanas, J.N.; Papazoglou, P.P.; Terrovitis, J.V.; Kanakakis, J.; Dalianis, A.; Tsolakis, E.; Tsagalou, E.P.; Agrios, N.; Christodoulou, K.; Anastasiou-Nana, M.I. 2004: Hemodynamic effects of levosimendan added to dobutamine in patients with decompensated advanced heart failure refractory to dobutamine alone American Journal of Cardiology 94(10): 1329-1332
Cheitlin, M.D. 2006: Hemodynamic Effects of Levosimendan Added to Dobutamine in Patients With Decompensated Advanced Heart Failure Refractory to Dobutamine Alone Yearbook of Cardiology 2006: 329-331
Buser P.T.; Auffermann W.; Wu S.T.; Parmley W.W.; Wikmann Coffelt J. 1990: Energetics and mechanics in moderate and advanced heart failure during treatment with amrinone and amrinone plus dobutamine a phosphorus 31 mrs study Journal of the American College of Cardiology 15(2 Suppl A): 208A